Особенности иммунного статуса больных миомой матки и раком эндометрия
Published in Vestnik of Lobachevsky State University of Nizhni Novgorod Series Social Sciences • Jan 1, 2012
NobleIDNI5P80W84R84S43
Authors:,,
Янченко Ольга Сергеевна
Конторщикова Елена Юрьевна
Шахова Ксения Андреевна
Abstract
In Trial 23 the current data suggest that early or adjuvant therapy may not benefit patients at low risk for recurrence, such as those with localized disease. The findings of Trial 23 contrast with the results in the overall early prostate cancer program and in other published literature, in which b...